	potassium excretion	13.013263106390816
	sodium excretion	10.973024836408921
	urine excretion	10.733711143206321
¡°	amiloride hydrochloride	7.321851292291344
	excessive excretion	6.898522012669193
¡°	diuretic agent	5.261842718216044
¡°	amiloride hydrochlorothiazide combination	4.912237718918633
	potassium conserving	3.531679696732689
	potassium ion	3.289626288451944
¡°	effective diuretic natriuretic agent	3.104661879126571
¡°	diuretic formulation	2.6319016865878426
	Hydrochlorothiazide	2.5026109051637726
	natriuretic synergism	2.001381719591295
	known potassium excreting	1.993407665164554
	Lamberti	1.6692292808993214
	novel pyrazinoylguanidine	1.3922938981047788
	filing	1.270693053671885
	sodium ion	1.2493880184700492
	desirable sodium potassium eliminate property	1.1283586589270131
	diuresis	0.8350261861970659
	hypokalemia	0.8350261861970659
	triamterene	0.8350261861970659
	Susi	0.8350261861970659
	Moduretic	0.8346146404496607
	medically synergistic therapeutic accomplishment	0.8280956414554517
	particularly sodium	0.6569904231837324
	allege synergistic effect	0.6011967423750276
	spironolactone	0.48166518229959937
	renal disease	0.4368847693764283
	hydrated zeolite	0.42220442427025817
	physical exhaustion	0.42082320896902325
	Discussion	0.33576477005199695
	suit	0.32541398357690826
	various Diuretic Formulations	0.29275102336408765
	increase electrolyte	0.24394145127751124
	unpreferred embodiment	0.24112390533190098
	Schaumann	0.16806258556843395
	Corkill	0.16606858720657414
	mg	0.16241380078384554
	Drug Price Competition Patent Term Restoration Act	0.12375310326140619
	detergent formulation	0.12078027871261789
	oral administration	0.11529753496497137
	co administration	0.10985610718457324
	determinative importance	0.10763693242817017
	appellant additive	0.09386984661334119
	specific ratio	0.08994189363734419
	random variation	0.08833049901996039
	severe muscle weakness	0.08005660567915594
	O'Farrell	0.07960830138099775
	Petering	0.0698866444866985
	wherein ratio	0.06748567700620427
	Mayer	0.05132476161404529
	Applicant	0.042405012174763536
	abbreviate drug applicant	0.04098121855984897
	dosage limitation	0.0395528935614805
	specific preference	0.03886297502223796
	abbreviate drug application	0.03275692722210382
	New Jersey	0.030474679147525944
	Infringement Suit	0.02587863494290239
	thousand	0.02120256811223196
	undue significance	0.02047714579956633
	undesirable property	0.01942993768294732
	therapeutic effect	0.018879207815190646
	combine drug	0.01740571939732463
	individual drug	0.017328287922860952
	chemical genus	0.01699917041394743
	belief	0.016626634666422307
	numerous parameter	0.016463941892671183
	CCPA	0.01483164685872777
	ANDA	0.014543457679138932
	particular formulation	0.013076887441326157
	specific compound	0.012558649621348566
	Background	0.011267367101142707
	FDA	0.011261813937551459
	neither purported effect	0.010949985226712264
	nonobviousness	0.008708667595639095
	composition	0.00800333004530142
	generic formula	0.00793943385571364
	Food Drug Administration	0.0077463576942349704
	holder	0.00712473516524811
	success	0.006532803233029057
	connection	0.005300558867211068
	either indication	0.004679380308170533
	generic manufacturer	0.004632154034361212
	combination prima facie	0.0044956077016719475
	generic version	0.004340585556640796
	appellant generic	0.003686109483877336
	many possible choice	0.002630494855236061
	weight	0.002084503817968332
	effective combination	0.0020793416194515406
	six	0.0016414314738403977
	technical act	0.0014011334478952686
	inequitable conduct	0.0013753367858824331
	anticipation	0.0012593209865479687
	mere absence	0.0007188221279205905
	sale	0.0005423073468393187
	section	0.00046945569835060567
	prior art teaching	0.0004430224259724517
	obviousness rejection	0.00042294773906898284
	limited number	0.00041814934822380806
	identical purpose	0.00040626274390780526
	propose manufacture	0.0003699271086212849
	owner	0.000295685179512777
	specific embodiment	0.0002641282320200706
	validity aspect	0.00021165489494789737
	burden	0.0001812159583106504
	description	0.00014850983244483508
	disclosure	9.506769195628227e-05
	clear convincing evidence	6.331120455443058e-05
	Trademark Office	6.120342167415629e-05
	another	3.359208669736896e-05
	favor	2.275172229517735e-05
	factual finding	2.2691784127878324e-05
	element	2.1229327467084207e-05
	inventor	1.9027061399216507e-05
	Claim	1.2783876964621978e-05
	trial	1.189387704880149e-05
	U.S.C.	1.1014144963642601e-05
	single reference	1.0051802220323701e-05
	scope	5.971709799296418e-06
	district court finding	4.854963564553944e-06
	relevant part	3.390367686815537e-06
	conclusion	2.26553208473865e-06
	light	1.3759669212696176e-06
	argument	2.0881155100782424e-07
	action	1.2158719295998852e-07
	law	9.612383585629354e-08
	question	4.601298234453336e-08
	party	3.2057065098017135e-08
	two prior art	1.3563048566915443e-08
	judgment	6.456106939001568e-09
	invention	5.356445931225078e-09
	use	4.025956914089166e-09
	issue	1.100814120548565e-09
	Co.	8.917312870833494e-10
	District	0.0
	Court	0.0
	Appeals	0.0
	Inc.	0.0
	Fed	0.0
